ACADIA Pharmaceuticals

ACADIA Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing treatments for central nervous system disorders and rare diseases. Its mission is to elevate life through innovation in neuroscience. Key products include NUPLAZID (pimavanserin) for hallucinations and delusions associated with Parkinson's disease psychosis, and DAYBUE (trofinetide) for Rett syndrome.